Latest news
OrbiMed discloses sub-10% Yarrow Bioscience, Inc. (Ticker: VYNE) stake and large warrants - Stock TitanStock Titan · Thu, 06 Aug 2026 02:18:28 GMTBiogen Inc. completed the acquisition of RayThera, Inc. from Foresite Capital Management, LLC, OrbiMed Advisors LLC, TTM Capital and others. - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 22:00:00 GMTADQ-anchored Lunate, Orbimed, Creaegis invest in Indian healthcare firm - VCCircleVCCircle · Thu, 30 Jul 2026 11:41:58 GMTOrbiMed Advisors Discloses Investment in Scribe Therapeutics with 7.2% Stake - tradingview.comtradingview.com · Wed, 29 Jul 2026 22:46:00 GMTOrbiMed discloses pre-funded warrants in Yarrow Bioscience, Inc. (VYNE) - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTYarrow Bioscience, Inc. (VYNE) director reports large OrbiMed warrants - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTOrbimed Advisors LLC Reduces Stock Holdings in Oric Pharmaceuticals, Inc. $ORIC - MarketBeatMarketBeat · Mon, 27 Jul 2026 10:38:42 GMTOrbimed Advisors LLC Acquires 150,000 Shares of Bristol Myers Squibb Company $BMY - MarketBeatMarketBeat · Mon, 27 Jul 2026 10:16:27 GMT